Rituximab, interferon-alfa-2b and dose dense CVP is highly efficient in patients with FLIPI ≥ 2 follicular lymphoma. Final results of the LNH-PRO-05 study
- Cannata-Ortiz, J.
- Nicolás, C.
- García-Noblejas, A.
- Requena, M.J.
- López-Jiménez, J.
- Alaez Uson, C.
- Arranz, R.
ISSN: 1365-2141, 0007-1048
Argitalpen urtea: 2019
Alea: 186
Zenbakia: 1
Orrialdeak: 168-170
Mota: Gutuna